Sun ready to roll with Ranbaxy; House arrest for driver in Lilly warehouse burglary; Rentschler adds bioreactor;

> With its last approval in hand, Sun Pharmaceutical is closing its $4 billion deal to buy Ranbaxy Laboratories. Story

> German CDMO Rentschler Biotechnologie has doubled its single-use manufacturing capabilities with a new 2,000L bioreactor. Release

> The Paris plant of French biotech Theravectys has been granted regulatory approval to manufacture lentiviral vectors for clinical development purposes and to manipulate human cells in the context of chimeric antigen receptors (CARs) and T-cell receptor (TCR)-based cell therapies. Report

> In a follow-up report on the World Health Organization meeting on counterfeit drugs, it has laid out tasks for certain countries to move forward on finding ways to reduced the number of counterfeits being sold. Report (PDF)

And Finally... A man who claimed he was fooled into being a lookout and driver in the record-setting burglary of an Eli Lilly ($LLY) warehouse in 2010 has been sentenced to 6 months of house arrest. Story

Suggested Articles

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back. 

The lawmakers question Kodak's fitness for such a major pharma manufacturing deal, as well as suspicious stock transactions by company leadership.

AZ's China COVID-19 vaccine deal comes after supply agreements with the U.S., the U.K., EU and Brazil, as well as licensing pacts in India and Japan.